Fresenius Medical Care AG & Co. KGaA

Earnings Release • Feb 21, 2012

News Details

Ad-hoc | 21 February 2012 06:58

Fresenius Medical Care AG & Co. KGaA: Reports Record Full Year 2011 Results and provides Outlook for 2012

Fresenius Medical Care AG & Co. KGaA / Key word(s): Final Results/Forecast

21.02.2012 06:58

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Fresenius Medical Care Reports Record Full Year 2011 Results and provides
Outlook for 2012

Net revenue of Fresenius Medical Care AG & Co. KGaA for the full year 2011
was $12,795 million, up by 6% from the full year 2010.

Operating income (EBIT) for the full year 2011 was $2,075 million, up by 8%
from the full year 2010.

For the full year 2011, net income attributable to shareholders of
Fresenius Medical Care AG & Co. KGaA was $1,071 million, up 9% from the
full year 2010.

For the 15th consecutive year shareholders can expect to receive an
increased annual dividend. At the Annual General Meeting to be held on May
10, 2012, shareholders will be asked to approve a dividend per ordinary
share of EUR0.69, an increase of 6% (2010: EUR0.65).

For the full year 2012, Fresenius Medical Care expects revenue to grow to
around $14 billion. This revenue guidance takes into account the first time
adoption in 2012 of an U.S. - GAAP accounting change in the presentation of
U.S. dialysis service revenue which will be shown net of the provision for
bad debt. Based on the comparable revenue for 2011 of $12,571 million, the
revenue guidance represents an increase of 11% and between 13% and 15%
based on constant currency.

Net income is expected to grow to around $1.3 billion and net income
attributable to shareholders of Fresenius Medical Care AG & Co. KGaA is
expected to grow to around $1.14 billion with operating margins forecast to
increase by approximately 70 basis points to 16.9%.

For 2012, Fresenius Medical Care expects to spend around $700 million on
capital expenditure and approximately $1.8 billion on acquisitions.

Fresenius SE & Co. KGaA (WKN 578560) holds approximately 30.9% of Fresenius
Medical Care AG & Co. KGaA's capital.

Fresenius Medical Care AG & Co. KGaA,
Represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., February 21, 2012

21.02.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir@fmc-ag.com
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; NYSE

End of Announcement DGAP News-Service

---